The answer sort of depends on what you mean by moonshot, but under one reasonable definition, it’s actually the opposite: investing in potential moonshots would have resulted in worse performance than an index fund. Or to put it another way, boring companies tend to outperform exciting companies.
You can divide stocks into two types: growth stocks and value stocks. Value stocks are cheaply priced relative to their fundamentals (e.g., they have a low price to earnings or price to sales ratio) because the market expects these companies to be “boring” and not show good earnings growth. Growth stocks are priced expensively because the market expects them to grow. This sounds basically like what you’re talking about with “moonshot” companies. If you wanted to systematically invest in moonshots, you could maybe buy the 10% most expensive stocks, because these are the ones the market believes have the most upside potential. But if you did that historically, you would’ve underperformed the market by a lot—something on the order of 5 percentage points per year. The seminal paper on this is Fama & French (1992), The Cross-Section of Expected Stock Returns.
In theory, savvy investors could identify the most promising publicly-traded growth companies and outperform the market by buying them. But studies on fund managers have found that pretty much nobody can do this.
The answer sort of depends on what you mean by moonshot, but under one reasonable definition, it’s actually the opposite: investing in potential moonshots would have resulted in worse performance than an index fund. Or to put it another way, boring companies tend to outperform exciting companies.
You can divide stocks into two types: growth stocks and value stocks. Value stocks are cheaply priced relative to their fundamentals (e.g., they have a low price to earnings or price to sales ratio) because the market expects these companies to be “boring” and not show good earnings growth. Growth stocks are priced expensively because the market expects them to grow. This sounds basically like what you’re talking about with “moonshot” companies. If you wanted to systematically invest in moonshots, you could maybe buy the 10% most expensive stocks, because these are the ones the market believes have the most upside potential. But if you did that historically, you would’ve underperformed the market by a lot—something on the order of 5 percentage points per year. The seminal paper on this is Fama & French (1992), The Cross-Section of Expected Stock Returns.
In theory, savvy investors could identify the most promising publicly-traded growth companies and outperform the market by buying them. But studies on fund managers have found that pretty much nobody can do this.